Featured Research

from universities, journals, and other organizations

MR Spectroscopy May Be Superior For Determining Prostate Cancer Prognosis

Date:
April 18, 2005
Source:
Massachusetts General Hospital
Summary:
A new way of evaluating prostate tumors may help physicians determine the best treatment strategy. Using magnetic resonance spectroscopy, MGH researchers have shown that chemical profiles of prostate tissue can determine a tumor's prognosis better than standard pathological studies do.

A new way of evaluating prostate tumors may help physicians determine the best treatment strategy. Using magnetic resonance (MR) spectroscopy, which provides detailed information on the chemical composition of tissue samples, researchers from Massachusetts General Hospital (MGH) have shown that chemical profiles of prostate tissue can determine a tumor's prognosis better than standard pathological studies do. The report appears in the April 15 issue of Cancer Research.

Related Articles


"Our study indicates that analyzing prostate tissue's metabolic profile may give clinicians additional information about the biologic status of the disease that could allow them, in consultation with their patients, to make better-informed decisions on the next steps to take," says Leo L. Cheng, PhD, of the MGH Radiology and Pathology Departments, the report's lead author.

Since the prostate-specific antigen (PSA) test became widely used to screen for prostate cancer, tumor detection rates have increased dramatically, particularly among those at early stages of the disease. But increased detection has led to a clinical dilemma, since standard histologic evaluation, based on a biopsy sample's appearance under a microscope, often cannot distinguish which tumors are going to spread and which are not. Many men live for years with slow-growing prostate tumors before they die of unrelated causes, and treating such patients could cause more harm than benefit, Cheng notes. So finding a better way to determine which patients need aggressive treatment and which can try watchful waiting has been a major challenge.

Another problem is that a biopsy sample from one area the prostate may miss malignant cells elsewhere in the gland. Removal of the entire prostate can give a more definitive diagnosis, but if the tumor is a slow-growing one, the patient would have undergone unnecessary surgery. Surgery also is not appropriate when cancer has already spread beyond the prostate, since that situation requires other therapeutic approaches such a chemotherapy or drugs that block testosterone's action.

Although MR spectroscopy has been used for many years to measure the chemical composition of materials, including biological samples, it has not been useful for analyzing tumor specimens. In recent years, Cheng and his colleagues have been developing a spectroscopic technique called high-resolution magic angle spinning that provides detailed analysis of a sample's components without destroying its cellular structure. The current study was designed to evaluate the technique's potential for providing information useful for clinical decision-making in prostate cancer.

The researchers used MR spectroscopy to analyze tissue samples from 82 patients in whom prostate cancer had been confirmed by prostatectomy. Almost 200 separate samples were studied, including many that appeared benign to standard histological examination. They then compared the spectroscopy results -- detailed profiles of each sample's chemical components -- with the information gathered from pathological analyses of the removed glands and the patients' clinical outcomes.

Several chemical components of the tissue samples were found to correlate with the tumors' invasiveness and aggressiveness, supporting the potential of these metabolic profiles to provide valuable clinical information. Perhaps most significantly, even samples of apparently benign tissue had components that could successfully identify more and less aggressive tumors elsewhere in the prostate.

"Not only are the spectroscopy studies as good as histopathology in differentiating cancer cells from benign cells, they may be even better if they can find these metabolic differences in tissues that look benign," says Cheng. "We need to do a larger scale, more systematic study of this technique before it can be applied to clinical practice. And we hope to collaborate with other institutions to identify different metabolic profiles that could provide additional information." Cheng is an assistant professor of Radiology and Pathology at Harvard Medical School.

###

The study's co-authors are Melissa Burns, Jennifer Taylor, Chin-Lee Wu, MD, PhD, and Wenlei He, MD, PhD, of MGH Pathology; Elkan Halpern, PhD, MGH Radiology; and Scott McDougal, MD, chief of MGH Urology. The study was supported by grants from the National Institutes of Health and the U.S. Department of Defense.

Massachusetts General Hospital, established in 1811, is the original and largest teaching hospital of Harvard Medical School. The MGH conducts the largest hospital-based research program in the United States, with an annual research budget of more than $450 million and major research centers in AIDS, cardiovascular research, cancer, cutaneous biology, medical imaging, neurodegenerative disorders, transplantation biology and photomedicine. In 1994, MGH and Brigham and Women's Hospital joined to form Partners HealthCare System, an integrated health care delivery system comprising the two academic medical centers, specialty and community hospitals, a network of physician groups, and nonacute and home health services.


Story Source:

The above story is based on materials provided by Massachusetts General Hospital. Note: Materials may be edited for content and length.


Cite This Page:

Massachusetts General Hospital. "MR Spectroscopy May Be Superior For Determining Prostate Cancer Prognosis." ScienceDaily. ScienceDaily, 18 April 2005. <www.sciencedaily.com/releases/2005/04/050418094145.htm>.
Massachusetts General Hospital. (2005, April 18). MR Spectroscopy May Be Superior For Determining Prostate Cancer Prognosis. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2005/04/050418094145.htm
Massachusetts General Hospital. "MR Spectroscopy May Be Superior For Determining Prostate Cancer Prognosis." ScienceDaily. www.sciencedaily.com/releases/2005/04/050418094145.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins